Biotechnology Letters

, Volume 31, Issue 12, pp 1825–1835

Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part B: Delivery systems for BMPs in orthopaedic and craniofacial tissue engineering

  • Ziyad S. Haidar
  • Reggie C. Hamdy
  • Maryam Tabrizian


Localized and release-controlled delivery systems for the sustained expression of the biologic potency of rhBMPs are essential. A substantial number of biomaterials have been investigated thus far. Most fail after implantation or administration mainly due to either being too soft, difficult to control and/or stabilize mechanically. In the second part of this review, we review a representative selection of rhBMP-2 and rhBMP-7 carrier materials and delivery systems ranging from simple nano/microparticles to complex 3-D scaffolds in sites of orthopaedic and craniofacial bone regeneration and repair.


Biomaterials Bone morphogenetic proteins Bone regeneration Controlled-release Nanoparticles Synthetic polymers 


  1. Arosarena OA, Collins WL (2005) Bone regeneration in the rat mandible with bone morphogenetic protein-2: a comparison of two carriers. Otolaryngol Head Neck Surg 132:592–597CrossRefPubMedGoogle Scholar
  2. Barnes B, Boden SD, Louis-Ugbo J (2005) Lower dose of rhBMP-2 achieves spine fusion when combined with an osteoconductive bulking agent in non-human primates. Spine 30:1127–1133CrossRefPubMedGoogle Scholar
  3. Baskin DS, Ryan P, Sonntag V, Westmark R, Widmayer MA (2003) A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the CORNERSTONE-SR allograft ring and the ATLANTIS anterior cervical plate. Spine 28:1219–1224CrossRefPubMedGoogle Scholar
  4. Basmanav FB, Kose GT, Hasirci V (2008) Sequential growth factor delivery from complexed microspheres for bone tissue engineering. Biomaterials 29:4195–4204CrossRefPubMedGoogle Scholar
  5. Bessa PC, Casal M, Reis RL (2008) Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med 2:81–96CrossRefPubMedGoogle Scholar
  6. Bohner M, Baroud G (2005) Injectability of calcium phosphate pastes. Biomaterials 26:1553–1563CrossRefPubMedGoogle Scholar
  7. Boyne PJ, Lilly LC, Marx RE et al (2005) De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation. J Oral Maxillofac Surg 63:1693–1707CrossRefPubMedGoogle Scholar
  8. Burkus JK, Gornet MF, Dickman CA, Zdeblick TA (2002a) Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech 15:337–349PubMedGoogle Scholar
  9. Burkus JK, Transfeldt EE, Kitchel SH, Watkins RG, Balderston RA (2002b) Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2. Spine 27:2396–2408CrossRefPubMedGoogle Scholar
  10. Burkus JK, Sandhu HS, Gornet MF, Longley MC (2005) Use of rhBMP-2 in combination with structural cortical allografts: clinical and radiographic outcomes in anterior lumbar spinal surgery. J Bone Joint Surg Am 87:1205–1212CrossRefPubMedGoogle Scholar
  11. Chen RR, Mooney DJ (2003) Polymeric growth factor delivery strategies for tissue engineering. Pharm Res 20:1103–1112CrossRefPubMedGoogle Scholar
  12. Chen FM, Zhao YM et al (2007) Periodontal regeneration using novel glycidyl methacrylated dextran (Dex-GMA)/gelatin scaffolds containing microspheres loaded with bone morphogenetic proteins. J Control Release 121:81–90CrossRefPubMedGoogle Scholar
  13. De Long WG, Einhorn TA Jr et al (2007) Bone grafts and bone graft substitutes in orthopaedic trauma surgery. A critical analysis. J Bone Joint Surg Am 89:649–658CrossRefPubMedGoogle Scholar
  14. Engstrand T, Veltheim R, Arnander C, Docherty-Skogh AC, Westermark A, Ohlsson C, Adolfsson L, Larm O (2008) A novel biodegradable delivery system for bone morphogenetic protein-2. Plast Reconstr Surg 121:1920–1928CrossRefPubMedGoogle Scholar
  15. Fei Z, Hu Y, Wu D, Wu H et al (2008) Preparation and property of a novel bone graft composite consisting of rhBMP-2 loaded PLGA microspheres and calcium phosphate cement. J Mater Sci Mater Med 19:1109–1116CrossRefPubMedGoogle Scholar
  16. Friedlaender GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF et al (2001) Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 83A:151–158Google Scholar
  17. Fu TS, Chen WJ, Chen LH et al (2008) Enhancement of posterolateral lumbar spine fusion using low-dose rhBMP-2 and cultured marrow stromal cells. J Orthop Res (Epub ahead of print)Google Scholar
  18. Gao T, Uludag H (2001) Effect of molecular weight of thermoreversible polymer on in vivo retention of rhBMP-2. J Biomed Mater Res 57:92–100CrossRefPubMedGoogle Scholar
  19. Gautschi OP, Frey SP, Zellweger R (2003) Bone morphogenetic proteins in clinical applications. ANZ J Surg 77:626–631CrossRefGoogle Scholar
  20. Geesink RG, Hoefnagels NH, Bulstra SK (1999) Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect. J Bone Joint Surg Br 81:710–718CrossRefPubMedGoogle Scholar
  21. Geiger M, Li RH et al (2003) Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev 55:1613–1629CrossRefPubMedGoogle Scholar
  22. Ginebra MP, Traykova T, Planell JA (2006) Calcium phosphate cements as bone drug delivery systems: a review. J Control Release 113:102–110CrossRefPubMedGoogle Scholar
  23. Gittens SA, Uludag H (2001) Growth factor delivery for bone tissue engineering. J Drug Target 9:407–429PubMedCrossRefGoogle Scholar
  24. Govender S, Csimma C, Genant HK et al (2002) BMP-2 Evaluation in Surgery for Tibial Trauma (BESTT) Study Group. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 84:2123–2134CrossRefPubMedGoogle Scholar
  25. Haddad AJ, Peel SA, Clokie CM, Sándor GK (2006) Closure of rabbit calvarial critical-sized defects using protective composite allogeneic and alloplastic bone substitutes. J Craniofac Surg 17:926–934CrossRefPubMedGoogle Scholar
  26. Haidar ZS, Hamdy RC, Tabrizian M (2008a) Protein release kinetics for core-shell hybrid nanoparticles based on the layer-by-layer assembly of alginate and chitosan on liposomes. Biomaterials 29:1207–1215CrossRefPubMedGoogle Scholar
  27. Haidar ZS, Azari F, Hamdy RC, Tabrizian M (2008b) Modulated release of OP-1 and enhanced pre-osteoblast differentiation using a core-shell nanoparticulate system J Biomed Mater Res A (in press)Google Scholar
  28. Haidar ZS, Tabrizian M, Hamdy RC (2009) A hybrid OP-1 delivery system enhances new bone regeneration and consolidation in a rabbit model of distraction osteogenesis. Growth Factors (in press)Google Scholar
  29. Herford AS, Boyne PJ (2008) Reconstruction of mandibular continuity defects with bone morphogenetic protein-2 (rhBMP-2). J Oral Maxillofac Surg 66:616–624CrossRefPubMedGoogle Scholar
  30. Hosseinkhani H, Hosseinkhani M, Tian F, Kobayashi H, Tabata Y (2007) Bone regeneration on a collagen sponge self-assembled peptide-amphiphile nanofiber hybrid scaffold. Tissue Eng 13:11–19CrossRefPubMedGoogle Scholar
  31. Hu YY, Zhang C, Lu R, Xu JQ, Li D (2003) Repair of radius defect with bone-morphogenetic-protein loaded hydroxyapatite/collagen-poly(l-lactic acid) composite. Chin J Traumatol 6:67–74PubMedGoogle Scholar
  32. Issa JP, Nascimento C, Bentley MV et al (2008a) Bone repair in rat mandible by rhBMP-2 associated with two carriers. Micron 39:373–379CrossRefPubMedGoogle Scholar
  33. Issa JP, Spadaro AC, Bentley MV et al (2008b) Monoolein and chitosan gels as potential carriers of the rhBMP-2, using decortication surgical technique in Wistar rats as experimental model. Micron 39:952–959CrossRefPubMedGoogle Scholar
  34. Itoh T, Mochizuki M, Nishimura R et al (1998) Repair of ulnar segmental defect by recombinant human bone morphogenetic protein-2 in dogs. J Vet Med Sci 60:451–458CrossRefPubMedGoogle Scholar
  35. Johnsson R, Strömqvist B, Aspenberg P (2002) Randomized radiostereometric study comparing osteogenic protein-1 (BMP-7) and autograft bone in human noninstrumented posterolateral lumbar fusion: 2002 Volvo award in clinical studies. Spine 27:2654–2661CrossRefPubMedGoogle Scholar
  36. Jung RE, Glauser R, Schärer P, Hämmerle CH, Sailer HF, Weber FE (2003) Effect of rhBMP-2 on guided bone regeneration in humans. Clin Oral Implants Res 14:556–568CrossRefPubMedGoogle Scholar
  37. Jung RE, Weber FE et al (2008) Bone morphogenetic protein-2 enhances bone formation when delivered by a synthetic matrix containing hydroxyapatite/tricalciumphosphate. Clin Oral Implants Res 19:188–195CrossRefPubMedGoogle Scholar
  38. Kanayama M, Hashimoto T, Shigenobu K (2006) A prospective randomized study of posterolateral lumbar fusion using osteogenic protein-1 (OP-1) versus local autograft with ceramic bone substitute: emphasis of surgical exploration and histologic assessment. Spine 31:1067–1074CrossRefPubMedGoogle Scholar
  39. Kawakatsu N, Oda S, Kinoshita A et al (2008) Effect of rhBMP-2 with PLGA/gelatin sponge type (PGS) carrier on alveolar ridge augmentation in dogs. J Oral Rehabil 35:647–655CrossRefPubMedGoogle Scholar
  40. Kenley R, Marden L, Turek T, Jin L, Ron E, Hollinger JO (1994) Osseous regeneration in the rat calvarium using novel delivery systems for recombinant human bone morphogenetic protein-2 (rhBMP-2). J Biomed Mater Res 28:1139–1147CrossRefPubMedGoogle Scholar
  41. Kim HD, Valentini RF (2002) Retention and activity of BMP-2 in hyaluronic acid-based scaffolds in vitro. J Biomed Mater Res 59:573–584CrossRefPubMedGoogle Scholar
  42. Kim SS, Gwak SJ, Kim BS (2008) Orthotopic bone formation by implantation of apatite-coated poly(lactide-co-glycolide)/hydroxyapatite composite particulates and bone morphogenetic protein-2. J Biomed Mater Res A 87:245–253PubMedGoogle Scholar
  43. Kneser U, Schaefer DJ, Polykandriotis E, Horch RE (2006) Tissue engineering of bone: the reconstructive surgeon’s point of view. J Cell Mol Med 10:7–19CrossRefPubMedGoogle Scholar
  44. Kretlow JD, Klouda L, Mikos AG (2007) Injectable matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev 59:263–273CrossRefPubMedGoogle Scholar
  45. Kumar MN, Muzzarelli RA, Muzzarelli C, Sashiwa H, Domb AJ (2004) Chitosan chemistry and pharmaceutical perspectives. Chem Rev 104:6017–6084CrossRefPubMedGoogle Scholar
  46. Kwon B, Jenis LG (2005) Carrier materials for spinal fusion. Spine J 5(6):S224–S230CrossRefGoogle Scholar
  47. Lee SH, Shin H (2007) Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. Adv Drug Deliv Rev 59(4–5):339–359CrossRefPubMedGoogle Scholar
  48. Lee KY, Yuk SH (2007) Polymeric protein delivery systems. Prog Poly Sci 32:669–697CrossRefGoogle Scholar
  49. Li RH, Wozney JM (2001) Delivering on the promise of bone morphogenetic proteins. Trend Biotechnol 19:255–265CrossRefGoogle Scholar
  50. Liew CV, Chan LW, Ching AL, Heng PW (2006) Evaluation of sodium alginate as drug release modifier in matrix tablets. Int J Pharm 309:25–37CrossRefPubMedGoogle Scholar
  51. Luginbuehl V, Meinel L et al (2004) Localized delivery of growth factors for bone repair. Eur J Pharm Biopharm 58:197–208CrossRefPubMedGoogle Scholar
  52. Ma PX (2008) Biomimetic materials for tissue engineering. Adv Drug Deliv Rev 60:184–198CrossRefPubMedGoogle Scholar
  53. Mandu-Hrit M, Haque T, Lauzier D, Kotsiopriftis M, Rauch F, Tabrizian M, Henderson JE, Hamdy RC (2006) Early injection of OP-1 during distraction osteogenesis accelerates new bone formation in rabbits. Growth Factors 24:172–183CrossRefPubMedGoogle Scholar
  54. Maniscalco P, Gambera D, Bertone C et al (2002) Healing of fresh tibial fractures with OP-1. Acta Biomed 73:27–33PubMedGoogle Scholar
  55. Mayer M, Hollinger J, Ron E, Wozney J (1996) Maxillary alveolar cleft repair in dogs using recombinant human bone morphogenetic protein-2 and a polymer carrier. Plast Reconstr Surg 98:247–259CrossRefPubMedGoogle Scholar
  56. Moioli EK, Clark PA, Xin X, Lal S, Mao JJ (2007) Matrices and scaffolds for drug delivery in dental, oral and craniofacial tissue engineering. Adv Drug Deliv Rev 59:308–324CrossRefPubMedGoogle Scholar
  57. Moore WR, Graves SE, Bain GI (2001) Synthetic bone graft substitutes. ANZ J Surg 71:354–361CrossRefPubMedGoogle Scholar
  58. Mussano F, Ciccone G, Ceccarelli M, Baldi I, Bassi F (2007) Bone morphogenetic proteins and bone defects: a systematic review. Spine 32:824–830CrossRefPubMedGoogle Scholar
  59. Nair LS, Laurencin CT (2008) Nanofibers and nanoparticles for orthopaedic surgery applications. J Bone Joint Surg Am 90(S1):128–131CrossRefPubMedGoogle Scholar
  60. Noshi T, Yoshikawa T, Dohi Y (2001) Recombinant human bone morphogenetic protein-2 potentiates the in vivo osteogenic ability of marrow/hydroxyapatite composites. Artif Organs 25:201–208CrossRefPubMedGoogle Scholar
  61. O’Regan M, Martini I, Crescenzi F, De Luca C, Lansing M (1994) Molecular mechanisms and genetics of hyaluronan biosynthesis. Int J Bio Macromol 16:283–286CrossRefGoogle Scholar
  62. Okubo Y, Bessho K, Fujimura K et al (2000) Osteoinduction by recombinant human bone morphogenetic protein-2 at intramuscular, intermuscular, subcutaneous and intrafatty sites. Int J Oral Maxillofac Surg 29:62–66CrossRefPubMedGoogle Scholar
  63. Park JH, Ye M, Park K (2005) Biodegradable polymers for microencapsulation of drugs. Molecules 10:146–161CrossRefPubMedGoogle Scholar
  64. Peng L, Bian WG, Liang FH, Xu HZ (2008) Implanting hydroxyapatite-coated porous titanium with bone morphogenetic protein-2 and hyaluronic acid into distal femoral metaphysis of rabbits. Chin J Traumatol 11:179–185CrossRefPubMedGoogle Scholar
  65. Prabaharan M (2008) Chitosan derivatives as promising materials for controlled drug delivery. J Biomater Appl 23:5–36CrossRefPubMedGoogle Scholar
  66. Qiu Y, Zhang N, Kang Q, An Y, Wen X (2008) Chemically modified light-curable chitosans with enhanced potential for bone tissue repair. J Biomed Mater Res A [Epub ahead of print]Google Scholar
  67. Robinson Y, Heyde CE, Tschöke SK et al (2008) Evidence supporting the use of bone morphogenetic proteins for spinal fusion surgery. Expert Rev Med Dev 5:75–84CrossRefGoogle Scholar
  68. Saito N, Takaoka K (2003) New synthetic biodegradable polymers as BMP carriers for bone tissue engineering. Biomaterials 24:2287–2293CrossRefPubMedGoogle Scholar
  69. Saito N, Murakami N, Takahashi J et al (2005) Synthetic biodegradable polymers as drug delivery systems for bone morphogenetic proteins. Adv Drug Deliv Rev 57:1037–1048CrossRefPubMedGoogle Scholar
  70. Schliephake H, Weich HA, Dullin C, Gruber R, Frahse S (2008) Mandibular bone repair by implantation of rhBMP-2 in a slow release carrier of polylactic acid–an experimental study in rats. Biomaterials 29:103–110CrossRefPubMedGoogle Scholar
  71. Schmidmaier G, Schwabe P, Strobel C, Wildemann B (2008) Carrier systems and application of growth factors in orthopaedics. Injury 39(S2):37–43CrossRefGoogle Scholar
  72. Schopper C, Moser D, Spassova E et al (2008) Bone regeneration using a naturally grown HA/TCP carrier loaded with rh BMP-2 is independent of barrier-membrane effects. J Biomed Mater Res A 85:954–963PubMedGoogle Scholar
  73. Sciadini MF, Johnson KD (2000) Evaluation of recombinant human bone morphogenetic protein-2 as a bone-graft substitute in a canine segmental defect model. J Orthop Res 18:289–302CrossRefPubMedGoogle Scholar
  74. Seeherman H, Wozney JM (2005) Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. Cytokine Growth Factor Rev 16:329–345CrossRefPubMedGoogle Scholar
  75. Sigurdsson TJ, Nygaard L, Tatakis DN, Fu E, Turek TJ, Jin L, Wozney JM, Wikesjö UM (1996) Periodontal repair in dogs: evaluation of rhBMP-2 carriers. Int J Periodontics Restorative Dent 16:524–537PubMedGoogle Scholar
  76. Takaoka K, Koezuka M, Nakahara H (1991) Telopeptide-depleted bovine skin collagen as a carrier for bone morphogenetic protein. J Orthop Res 9:902–907CrossRefPubMedGoogle Scholar
  77. Talwar R, Di Silvio L, Hughes FJ, King GN (2001) Effects of carrier release kinetics on bone morphogenetic protein-2-induced periodontal regeneration in vivo. J Clin Periodontol 28:340–347CrossRefPubMedGoogle Scholar
  78. Termaat MF, Den Boer FC, Bakker FC, Patka P, Haarman HJ (2005) Bone morphogenetic proteins. Development and clinical efficacy in the treatment of fractures and bone defects. J Bone Joint Surg Am 87:1367–1378CrossRefPubMedGoogle Scholar
  79. Tönnesen HH, Karlsen J (2002) Alginate in drug delivery systems. Drug Dev Ind Pharm 28:621–630CrossRefPubMedGoogle Scholar
  80. Vaccaro AR, Anderson DG, Patel T et al (2005) Comparison of OP-1 Putty (rhBMP-7) to iliac crest autograft for posterolateral lumbar arthrodesis: a minimum 2-year follow-up pilot study. Spine 30:2709–2716CrossRefPubMedGoogle Scholar
  81. Vaccaro AR, Whang PG, Patel T (2008) The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study. Spine J 8:457–465CrossRefPubMedGoogle Scholar
  82. Välimäki VV, Aro HT (2006) Molecular basis for action of bioactive glasses as bone graft substitute. Scand J Surg 95:95–102PubMedGoogle Scholar
  83. van den Bergh JP, ten Bruggenkate CM, Groeneveld HH, Burger EH, Tuinzing DB (2000) Recombinant human bone morphogenetic protein-7 in maxillary sinus floor elevation surgery in 3 patients compared to autogenous bone grafts. A clinical pilot study. J Clin Periodontol 27(9):627–636CrossRefPubMedGoogle Scholar
  84. Wei G, Jin Q, Giannobile WV, Ma PX (2007) The enhancement of osteogenesis by nano-fibrous scaffolds incorporating rhBMP-7 nanospheres. Biomaterials 28:2087–2096CrossRefPubMedGoogle Scholar
  85. Woo BH, Jiang G, Jo YW, DeLuca PP (2001) Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery. Pharm Res 18:1600–1606CrossRefPubMedGoogle Scholar
  86. Yamamoto M, Takahashi Y, Tabata Y (2006) Enhanced bone regeneration at a segmental bone defect by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel. Tissue Eng 12:1305–1311CrossRefPubMedGoogle Scholar
  87. Young S, Wong M, Tabata Y, Mikos AG (2005) Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Control Rel 109:256–274CrossRefGoogle Scholar
  88. Zellin G, Linde A (1997) Importance of delivery systems for growth-stimulatory factors in combination with osteopromotive membranes. An experimental study using rhBMP-2 in rat mandibular defects. J Biomed Mater Res 35:181–190CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2009

Authors and Affiliations

  • Ziyad S. Haidar
    • 1
    • 2
    • 3
    • 4
  • Reggie C. Hamdy
    • 3
    • 4
  • Maryam Tabrizian
    • 1
    • 2
    • 3
  1. 1.Faculty of DentistryMcGill UniversityMontréalCanada
  2. 2.Department of Biomedical Engineering, Faculty of MedicineMcGill UniversityMontréalCanada
  3. 3.Center for Biorecognition and BiosensorsMcGill UniversityMontréalCanada
  4. 4.Shriners Hospital for Children and Division of OrthopaedicsMontreal Children’s Hospital, McGill UniversityMontréalCanada

Personalised recommendations